Site Map

Posts

‘Breaking the mold with RNA—a “RNAissance” of life science’ – npj Genomic Medicine

Beacon maps over 2300 lung cancer biomarkers in new global database – PBI Forum

New day for antibody-drug conjugates – Chemical & Engineering News

What makes a good antibody–drug conjugate? – Martin De Cecco, Daniel N. Galbraith & Lisa L. McDermottt

Beacon Targeted Therapies announces the launch of Beacon Oncolytic Viruses

Cell Therapy 2.0

Overcoming Challenges in the Development of Anticancer ADCs

Immuno-oncology cell therapies: commercial considerations and strategies for the new decade

Beacon Targeted Therapies announces the launch of Beacon Gene Therapy

Frontiers in Oncology – Perspective: Designing T-Cell Engagers With Better Therapeutic Windows

Hot Topics at CAR-TCR 2020

Assessment of Clinical Activity of PD-1 Checkpoint Inhibitor Combination Therapies Reported in Clinical Trials

TCR Therapies Summit 2020 Magazine

Drug developers take fresh aim at ‘guided-missile’ cancer drugs

CAR-TCR Europe Summit 2020 Magazine

World ADC London 2020 Magazine

Innate Killer Summit 2020 Magazine

From Mylotarg to Polivy: Ebbs and flows, successes and woes of ADCs

Trends & Forecasts – Tenacious ADCs

World ADC San Diego Magazine 2019

Biomarkers for Checkpoint Inhibition and Their Clinical Utility – Timothy James Fabisiak, B.A.

Bispecific antibodies: a mechanistic review of the pipeline Aran F. Labrijn, Maarten L. Janmaat, Janice M. Reichert & Paul W. H. I. Parren

Beacon Targeted Therapies Launches Beacon Adoptive Cell

The Evolving Shape of the ADC Market: The Widening Application of ADCs and Manufacturing Improvements Meeting Demand – Charlie Johnson, CEO of ADC Bio, adcbio.com

Antibodies to watch in 2019 – Hélène Kaplon & Janice M. Reichert

Pages

Biomarkers & Assays

Webinar Resources

Internal Comms

Our data charter

FAQS

Advanced Keyword Searches

News

Solutions

Request a demo

About

Contact

Events

Who’s it for?

Privacy Policy

Resource Center

Site Map

Terms & Conditions

Home

Solutions

Beacon Oncology

Beacon Cell Therapy

Biomarkers & Assays – Lung Cancer

Beacon Immune Tolerance

Beacon Microbiome

Beacon RNA

Beacon Cytokine

Beacon Cancer Vaccine

Beacon TPD

Beacon DDR

Beacon Oncolytic Viruses

Beacon Gene Therapy

Beacon Checkpoint

Beacon Bispecific

Beacon ADC

Events

Personalized Cancer Vaccine Summit 2024

15th World ADC San Diego Summit 2024

7th TPD & Induced Proximity Summit 2024

9th CAR-TCR Summit 2024

4th Induced Proximity-Based Drug Discovery Summit 2024

9th Microbiome Movement Drug Development Summit 2024

4th Oligonucleotides for CNS Summit 2024

ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit 2024

15th World Bispecific Summit 2024

3rd Cell Therapy Analytical Development Summit Europe

3rd World ADC Asia 2024

6th Annual Allogeneic Cell Therapies Summit 2024

4th Next Generation Gene Therapy Vectors Summit 2024

3rd Annual LNP Formulation & Process Development Summit

7th International Neoantigen Summit 2024

5th Cytokine-Based Drug Development Summit 2024

6th Cell Engager Summit 2024

6th Treg Directed Therapies Summit 2024

4th TPD Summit Europe 2024

8th Liquid Biopsy for Precision Oncology Summit

9th Innate Killer Summit

7th Antigen-Specific Immune Tolerance Drug Development Summit 2024

14th World ADC London 2024

2nd Molecular Glue Drug Development Summit

7th CAR-TCR Europe Summit 2024

3rd mRNA-Based Therapeutics Summit Europe 2024

8th Microbiome Movement – Drug Development Europe 2024

8th DDR Inhibitors Summit 2025

2nd Cell Therapy for Autoimmune Disease Summit

14th World Bispecifics Summit 2023

8th Oncolytic Virotherapy Summit 2023

6th Targeted Protein Degradation Summit

mRNA Cancer Vaccines Summit 2023

13th World Clinical Biomarkers & CDx Summit

8th CAR-TCR Summit 2023

4th Annual Gamma Delta T Therapies Summit 2023

14th World ADC San Diego 2023

3rd mRNA-Based Therapeutics Summit

5th Gene Therapy for Neurological Disorders Summit 2023

8th Microbiome Movement – Drug Development Summit

5th Annual Allogeneic Cell Therapies Summit

5th Treg Summit

4th STING & TLR Targeting Therapies Summit

4th Cytokine-Based Drug Development Summit

2nd LNP Formulation & Process Development Summit

5th Cell Engager Summit

6th Neoantigen Summit Europe

Webinars

Webinar – Unlocking the Future of RNA Therapeutics: Delivery System Evolution, Preclinical Insights, and Market Impact

Webinar – Novel Drug Conjugates and Clinical Success: An In-Depth Analysis of Emerging ADCs

Webinar – Exploring Allogeneic Cell Therapies: Pioneering Advantages and Recent Innovations

Webinar – Harnessing STING & TLR: Current Developments, Clinical Trials, and Key Players in the Landscape

Webinar – Inflammatory Bowel Disease: A Comprehensive Analysis of Drug and Market Trends

Webinar – Breaking Down AACR: A Comprehensive Review of DDR-Related Abstracts

Webinar – Navigating the Liquid Biopsy Landscape and the Role of ctDNA in Lung Cancer Research

Webinar – Decoding the Bivalent Degrader Landscape: Novel PROTACs, Developer Trends, and Future Innovations

Webinar – Exploring the Synergy of ADCs in Combination with Checkpoints: A Comprehensive Review

Webinar – The ADC Boom: Navigating the Expansive Landscape of Antibody-Drug Conjugates

Webinar – The Future of Cell Therapies: An In-Depth Analysis of the 2023 Commercial and Research Landscape

Webinar – Unlocking the Value of Microbiome-Targeting Therapeutics in Combating Infectious Diseases

Webinar – Bispecific Antibodies and Immune Checkpoint Modulators: A H1 Landscape Analysis

Webinar – Realizing the Full Potential within the RNA and Gene Therapy Landscapes: 2023 So Far

Webinar – Examining the Cytokine-Based Drug Development Landscape: Interleukins and Beyond

Webinar – T Cell Therapies: The Road Ahead for Addressing Autoimmune Indications

Webinar – The TPD Disease Landscape: Oncology vs. Non-Oncology

Webinar – Gene Therapy: Optimizing the Safety of Viral Vectors

Webinar – The DDR Landscape: The Past, Present & Future

Webinar – Landscape Analysis of Neoantigen Targeting Cancer Vaccines

Webinar – Three Generations of DDR Therapeutics

Infographics

In Vivo CAR Therapies – Cell Therapy Digest

Beacon Bispecific: SITC 2024 Post-Conference Report

Navigating the Complex Landscape of SKYSONA and Hematologic Cancer Report 2024

Strategic Insights for Biopharma Innovation Report

Cytokine TOI Digest Axatilimab Approval

DDRi and ADC Combination Therapies Infographic

2024年上半年抗体偶联药物研发格局回顾报告

H1 2024 Oncolytic Viruses Landscape Review

H1 2024 Cytokine Landscape Review

H1 2024 Cancer Vaccine Landscape Review

H1 2024 Microbiome Landscape Review

The 2024 H1 TPD Landscape Review

H1 2024 Immune Tolerance Landscape Review

The 2024 DDR H1 Landscape Review

H1 2024 Bispecific Landscape Review

H1 2024 RNA Landscape Review

H1 2024 Gene Therapy Landscape Review

H1 2024 Checkpoint Landscape Review

H1 2024 ADC Landscape Review

H1 2024 Cell Therapy Landscape Review

H1 2024 Lung Cancer Landscape Review

Unlocking the Potential of Bispecific ADCs

Beacon TPD: Induced Proximity Landscape Review 2024

ASCO 2024: Checkpoint Highlights

Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective

ASCO 2024: Cytokine Highlights

ASCO 2024: ADC Highlights

ASCO 2024: Bispecific Highlights

Beacon Immune Tolerance: 2024 EULAR Annual Meeting Abstracts

Beacon TPD: ASCO Post-Conference Report 2024

Beacon DDR: ASCO Post-Conference Report 2024

Unlock the Future of Advanced Therapies: Insights from the ASGCT 2024 Annual Meeting

Microbiome: US Market and LBP Development

Beacon Oncolytic Viruses: 2024 ASCO Annual Meeting Abstracts

Beacon Cancer Vaccine: 2024 ASCO Annual Meeting Abstracts

Beacon Cell Therapy: 2024 ASGCT Annual Meeting Abstracts

Beacon Gene Therapy: 2024 ASGCT Annual Meeting Abstracts

Microbiome: Drug Development in Asia Infographic

Antibodies & Biologics Landscape Reviews

Beacon DDR: AACR Post-Conference Report 2024

TPD: AACR Post-Conference Report 2024

Beacon RNA: AACR Post-Conference Report 2024

Charting the Course: Trends and Challenges in Early-Stage Cytokine-Based Drug Development Commercialization

2023年抗体偶联药物研发格局回顾性报告

Beacon DDR: AACR Pre-Conference Planner 2024

The 2023 Checkpoint Landscape Review

The 2023 Bispecific Landscape Review

The 2023 DDR Landscape Review

The 2023 ADC Landscape Review

The 2023 Cytokine Landscape Review

The 2023 TPD Landscape Review

The 2023 Lung Cancer, Biomarkers & Assays Landscape Review

2023 Gene Therapy Landscape Review

The 2023 RNA Landscape Review

2023 Cell Therapy Landscape Review

The 2023 Microbiome Landscape Review

2023 Immune Tolerance Landscape Review

Global Commercial Insights From the Bispecific and Multispecific Market

2023 Oncolytic Viruses Landscape Review

2023 Cancer Vaccine Landscape Review

The Rise of ADCs and Novel Drug Conjugates in Asia

Beacon Checkpoint: PD-L1: An Endless Classic or Passing Fancy?

Beacon Cell Therapy: ASH 2023 Conference Coverage

Liquid Biopsy Assays For ctDNA Detection Infographic

Beacon DDR: AACR-NCI-EORTC Post-Conference Report 2023

Beacon Gene Therapy: 2023 ASH Annual Meeting Abstracts

Monoclonal Antibodies (mAbs) Unveiled: A Comprehensive Review of the Landscape in Immune-Mediated Diseases Report 2023

Beacon TPD: ASH Conference Coverage 2023

RNA SITC Post-Conference Report 2023

Infographic 2023 Oncolytic Viruses ESMO Abstracts Analysis

The Rise of Bispecific Combination Trials Infographic

Beacon DDR: ESMO Post-Conference Report 2023

Cytokine: ESMO Congress 2023 Abstracts

Checkpoint: ESMO Congress 2023 Abstracts

Infographic 2023 Cancer Vaccine ESMO Abstracts Analysis

Beacon TPD: Next Generation Degraders Infographic

Editing Technologies Report 2023

The Checkpoint Disease Landscape: Exploring the Top Cancer Indications

The Preclinical Cytokine Review: An Analysis of the Latest Data

The Oligonucleotide Landscape Digest

SITC 2023 Cancer Vaccine Annual Meeting Abstracts

SITC 2023 Oncolytic Viruses Annual Meeting Abstracts

Allergies Report 2023

SITC 2023 Cell Therapy Annual Meeting Abstracts

Infographic 2023 Unlocking the Potential of mRNA Cancer Vaccines

The DDR Combination Therapies Infographic

‘A Landscape Review Of Lung Cancer’ Presentation

The 2023 H1 RNA Landscape Review

The H1 2023 Cytokine Landscape Review

H1 2023 Oncolytic Viruses Landscape Review

The H1 2023 DDR Landscape Review

H1 2023 Cancer Vaccine Landscape Review

The H1 2023 ADC Landscape Review

The H1 2023 Checkpoint Landscape Review

The H1 2023 Bispecific Landscape Review

The H1 2023 Microbiome Landscape Review

The 2023 H1 TPD Landscape Review

H1 2023 Cell Therapy Landscape Review

H1 2023 Gene Therapy Landscape Review

H1 2023 Immune Tolerance Landscape Review

Cancer Vaccine: Exploring Human Papillomavirus Infographic

ADC Preclinical Development: Where are we in 2023?

Gene Therapy: Lysosomal Storage Diseases – A Comprehensive Overview

Report 2023 Oncolytic Viruses Monotherapies vs Combinations

Checkpoint: The Adenosine-Pathway Clinical Trial Landscape

Bispecific: Landscape Review of Checkpoint-Targeting Bispecifics

TPD: ASCO 2023 Infographic

Microbiome: Milestones Infographic

Adoptive Cell: ASCO Annual Meeting 2023 Abstracts

Cytokine: ASCO Annual Meeting 2023 Abstracts

Bispecific: ASCO Annual Meeting 2023 Abstracts

ADC: ASCO Annual Meeting 2023 Abstracts

Oncolytic Viruses ASCO Post-Conference Report 2023

Cancer Vaccine ASCO Post-Conference Report 2023

AACR 2023: ADC Highlights and Insights

Cytokine & Adoptive Cell: Cytokine-Armored Cell Therapies

Checkpoint: ASCO Annual Meeting 2023 Abstracts

RNA: mRNA-Based Therapeutics Infographic

Oncolytic Viruses: ASGCT Annual Meeting 2023 Abstracts

Adoptive Cell: ASGCT Annual Meeting 2023 Abstracts

Gene Therapy: ASGCT Annual Meeting 2023 Abstracts

Cancer Vaccine Infographic 2023

Microbiome: Preclinical Models Infographic

Cytokine: AACR Annual Meeting 2023 Abstracts

ADC: AACR Annual Meeting 2023 Abstracts

Checkpoint: AACR Annual Meeting 2023 Abstracts

Bispecific: AACR Annual Meeting 2023 Abstracts

Oncolytic Viruses: AACR Annual Meeting 2023 Abstracts

Cancer Vaccine: AACR Annual Meeting 2023 Abstracts

Adoptive Cell: AACR Annual Meeting 2023 Abstracts

The 2022 Cytokine Landscape Review

The 2022 Checkpoint Landscape Review

The 2022 ADC Landscape Review

The 2022 Bispecific Landscape Review

The 2022 TPD Landscape Review

The 2022 Cancer Vaccine Landscape Review

The 2022 Oncolytic Viruses Landscape Review

The 2022 Adoptive Cell Landscape Review

TPD – The Molecular Glue Landscape: A Review

The 2022 Gene Therapy Landscape Review

Checkpoint: The TIGIT Axis Targeted Cancer Clinical Trial Landscape

Cytokine: A Spotlight on the TGF-β Cancer Clinical Trial Landscape

Beacon Gene Therapy – The Eye Disorder Landscape

Cancer Vaccine Infographic 2022

Microbiome: GI and Metabolic Diseases Infographic

Beacon Gene Therapy – Clinical Holds in the AAV Space

Checkpoint: Mid-Year Landscape Review 2022

ADC: Mid-Year Landscape Review 2022

Oncolytic Viruses: Mid-Year Landscape Review 2022

Cancer Vaccine: Mid-Year Landscape Review 2022

Gene Therapy: Mid-Year Landscape Review 2022

Adoptive Cell: Mid-Year Landscape Review 2022

4-1BB Landscape Review: Shift Towards a Bispecific Therapeutics Approach

Oncolytic Viruses – Vaccinia Virus Analysis

Adoptive Cell – Manufacturing Challenges & Considerations for Allogeneic Cell Therapy

Gene Therapy AAV Durability Report